These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 26459903)
21. In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan. Shen GH; Wu BD; Wu KM; Chen JH Antimicrob Agents Chemother; 2007 May; 51(5):1849-51. PubMed ID: 17353252 [TBL] [Abstract][Full Text] [Related]
22. Nontuberculous mycobacterial keratitis in south Florida. Ford JG; Huang AJ; Pflugfelder SC; Alfonso EC; Forster RK; Miller D Ophthalmology; 1998 Sep; 105(9):1652-8. PubMed ID: 9754173 [TBL] [Abstract][Full Text] [Related]
23. Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy. de la Cruz J; Behlau I; Pineda R J Cataract Refract Surg; 2007 Jul; 33(7):1318-21. PubMed ID: 17586393 [TBL] [Abstract][Full Text] [Related]
24. Antibiofilm effect of antimicrobials used in the therapy of mycobacteriosis. Flores VD; Siqueira FD; Mizdal CR; Bonez PC; Agertt VA; Stefanello ST; Rossi GG; Campos MM Microb Pathog; 2016 Oct; 99():229-235. PubMed ID: 27554273 [TBL] [Abstract][Full Text] [Related]
25. Effect of DNase and antibiotics on biofilm characteristics. Tetz GV; Artemenko NK; Tetz VV Antimicrob Agents Chemother; 2009 Mar; 53(3):1204-9. PubMed ID: 19064900 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria. Molina-Torres CA; Ocampo-Candiani J; Rendón A; Pucci MJ; Vera-Cabrera L Antimicrob Agents Chemother; 2010 May; 54(5):2188-90. PubMed ID: 20231398 [TBL] [Abstract][Full Text] [Related]
27. Rapidly growing mycobacterial infections: spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes. Sungkanuparph S; Sathapatayavongs B; Pracharktam R J Med Assoc Thai; 2003 Aug; 86(8):772-80. PubMed ID: 12948277 [TBL] [Abstract][Full Text] [Related]
28. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Shih MH; Huang FC Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):223-9. PubMed ID: 20811055 [TBL] [Abstract][Full Text] [Related]
29. Acinetobacter baumannii isolated from hospital-acquired infection: biofilm production and drug susceptibility. Krzyściak P; Chmielarczyk A; Pobiega M; Romaniszyn D; Wójkowska-Mach J APMIS; 2017 Nov; 125(11):1017-1026. PubMed ID: 28913903 [TBL] [Abstract][Full Text] [Related]
30. Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections. Mansour SC; de la Fuente-Núñez C; Hancock RE J Pept Sci; 2015 May; 21(5):323-9. PubMed ID: 25358509 [TBL] [Abstract][Full Text] [Related]
31. In Vitro Antimicrobial Susceptibility of Pathogenic Leptospira Biofilm. Vinod Kumar K; Lall C; Raj RV; Vedhagiri K; Sunish IP; Vijayachari P Microb Drug Resist; 2016 Oct; 22(7):511-514. PubMed ID: 26978023 [TBL] [Abstract][Full Text] [Related]
33. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. Cerca N; Martins S; Cerca F; Jefferson KK; Pier GB; Oliveira R; Azeredo J J Antimicrob Chemother; 2005 Aug; 56(2):331-6. PubMed ID: 15980094 [TBL] [Abstract][Full Text] [Related]
34. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates. Hoel T; Casals JB; Eng J APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323 [TBL] [Abstract][Full Text] [Related]
35. Delayed post-operative wound infections due to non-tuberculous Mycobacterium. Kalita JB; Rahman H; Baruah KC Indian J Med Res; 2005 Dec; 122(6):535-9. PubMed ID: 16518006 [TBL] [Abstract][Full Text] [Related]
36. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria. Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632 [TBL] [Abstract][Full Text] [Related]
37. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Jefferson KK; Goldmann DA; Pier GB Antimicrob Agents Chemother; 2005 Jun; 49(6):2467-73. PubMed ID: 15917548 [TBL] [Abstract][Full Text] [Related]
38. The efficacy of different anti-microbial metals at preventing the formation of, and eradicating bacterial biofilms of pathogenic indicator strains. Gugala N; Lemire JA; Turner RJ J Antibiot (Tokyo); 2017 Jun; 70(6):775-780. PubMed ID: 28196974 [TBL] [Abstract][Full Text] [Related]